These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 7791074)

  • 41. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
    NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor.
    Eisenberg RM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):985-91. PubMed ID: 8394926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
    Côté TE; Izenwasser S; Weems HB
    J Pharmacol Exp Ther; 1993 Oct; 267(1):238-44. PubMed ID: 8229750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
    Szatmári I; Orosz G; Medzihradszky K; Borsodi A
    Biochem Biophys Res Commun; 1999 Nov; 265(2):513-9. PubMed ID: 10558900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat.
    Tiseo PJ; Yaksh TL
    Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats.
    Soaje M; Bregonzio C; Carón RW; Deis RP
    Neuroendocrinology; 2004; 80(1):11-20. PubMed ID: 15340248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stress prevents the chronic ethanol-induced delta opiod receptor supersensitivity in the rat brain.
    Przewłocka B; Lasoń W
    Pol J Pharmacol Pharm; 1990; 42(2):137-42. PubMed ID: 2177189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization of Mu and delta opioid receptors to anterior cingulate afferents and projection neurons and input/output model of Mu regulation.
    Vogt BA; Wiley RG; Jensen EL
    Exp Neurol; 1995 Oct; 135(2):83-92. PubMed ID: 7589327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex.
    Kim KW; Son Y; Shin BS; Cho KP
    Life Sci; 2001 Feb; 68(11):1305-15. PubMed ID: 11233997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.